Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin

BACKGROUND: Breast cancer is a leading cause of death in women and with an increasing worldwide incidence. Doxorubicin, as a first-line anthracycline-based drug is conventional used on breast cancer clinical chemotherapy. However, the drug resistances limited the curative effect of the doxorubicin t...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhenchuan, Wang, Yong, Li, Chao, Zhang, Donghong, Wang, Xinle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437901/
https://www.ncbi.nlm.nih.gov/pubmed/25993398
http://dx.doi.org/10.1371/journal.pone.0127599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437901/
https://www.ncbi.nlm.nih.gov/pubmed/25993398
http://dx.doi.org/10.1371/journal.pone.0127599

Ejemplares similares